Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-76fb5796d-vfjqv Total loading time: 0 Render date: 2024-04-26T01:08:45.928Z Has data issue: false hasContentIssue false

Chapter 13 - Management of disease-related behavioral disturbances in Parkinson's disease

from Section II - Management of Nonmotor Symptoms of Parkinson's Disease

Published online by Cambridge University Press:  05 March 2016

By
Joseph H. Friedman
Edited by
Néstor Gálvez-Jiménez ,
Hubert H. Fernandez ,
Alberto J. Espay  and
Susan H. Fox
Néstor Gálvez-Jiménez
Affiliation:
Cleveland Clinic, Florida
Hubert H. Fernandez
Affiliation:
Cleveland Clinic, Ohio
Alberto J. Espay
Affiliation:
University of Cincinnati
Susan H. Fox
Affiliation:
Toronto Western Hospital
Get access

Summary

A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Chapter
Information
Parkinson's Disease
Current and Future Therapeutics and Clinical Trials
 , pp. 127 - 138
Publisher: Cambridge University Press
Print publication year: 2016

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Weintraub, D, Burn, D. Parkinson's disease: the quintessential neuropsychiatric disorder. Mov Disord 2011; 26: 1022–31.Google Scholar
Muller, B, Assus, J, Herlofson, K, Larsen, JP, Tysnes, OB. Importance of motor vs non-motor symptoms for health-related quality of life in early Parkinson's disease. Park Rel Disord 2013; 19: 1027–32.CrossRefGoogle ScholarPubMed
Rana, AQ, Athar, A, Owlia, A, et al. Impact of ethnicity on non-motor symptoms of Parkinson's disease. J Park Dis 2012; 2: 281–5.Google ScholarPubMed
Aarsland, D, Larsen, JP, Tanberg, E, Laake, K. Predictors of nursing home placement in Parkinson's disease: a population-based, prospective study. J Am Ger Soc 2000; 48: 938–42.CrossRefGoogle ScholarPubMed
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edn, Text Revision. Washington, DC: American Psychiatric Association Press, 1994.Google Scholar
Leentjens, AF, Dujardin, K, Marsh, L, et al. Anxiety and motor fluctuations in Parkinson's disease: a cross sectional observational study. Park Rel Disord 2012; 18: 1084–8.Google Scholar
Poletti, M, Bonuccelli, U. Personality traits in patients with Parkinson's disease: assessment and clinical implications. J Neurol 2012; 259: 1029–38.CrossRefGoogle ScholarPubMed
Noyce, AJ, Bestwick, JP, Silveira-Moriyama, L, et al. Meta-analysis of early non-motor symptoms and risk factors for Parkinson's disease. Ann Neurol 2012; 72: 893–901.CrossRefGoogle Scholar
Schifitto, G, Friedman, JH, Oakes, D, et al. Fatigue in levodopa-naive subjects with Parkinson's disease. Neurology 2008; 71: 481–5.Google Scholar
Jeliffe, SE. The parkinsonian body posture: some considerations on unconscious hostility. Psychoanal Rev 1940; 27: 467–79.Google Scholar
Sands, I. The type of personality susceptible to Parkinson's disease. J Mt Sinai Hosp 1942; 9: 792–4.Google Scholar
Poewe, W, Karamat, E, Kemmler, GW, Gerstenbrand, F. The premorbid personality of patients with Parkinson's disease: a comparative study with healthy controls and patients with essential tremor. Adv Neurol 1990; 53: 339–42.Google Scholar
Glosser, G, Clark, C, Freundlich, B, et al. A controlled investigation of current and premorbid personality: characteristics of Parkinson's disease patients. Mov Disord 1995; 19: 201–6.Google Scholar
Hubble, JP, Venkatesh, R, Hassanein, RE, Gray, C, Koller, WC. Personality and depression in Parkinson's disease. J Ner Ment Dis 1993; 181: 657–62.Google Scholar
Bower, JH, Grossardt, BR, Maraganore, DM, et al. Anxious personality predicts an increased risk of Parkinson's disease. Mov Disord 2010; 25: 2105–13.Google Scholar
Arabia, G, Grossardt, BR, Colligan, RC, et al. Novelty seeking and introversion do not predict the long-term risk of Parkinson disease. Neurology 2010; 75: 349–57.Google Scholar
Vieregge, P, Hagenah, J, Heberlein, I, Klein, C, Ludin, HP. Parkinson's disease in twins: a follow up study. Neurology 1999; 53: 566–72.CrossRefGoogle ScholarPubMed
Starkstein, SE. Apathy in Parkinson's disease: diagnostic and etiological dilemmas. Mov Disord 2012; 27: 174–8.Google Scholar
Chase, TN Apathy in neuropsychiatric diseases: diagnosis, pathophysiology and treatment. Neurotox Res 2011; 19: 266–78.Google Scholar
Robert, P, Onyike, CU, Leentjens, AF, et al. Proposed diagnostic criteria for apathy in Alzheimer's disease and other neuropsychiatric disorders. Eur Psychiatry 2009; 24: 98–104.Google Scholar
Marin, RS. Apathy: a neuropsychiatric syndrome. J Neuropsychiatry Clin Neurosci 1991; 3: 243–54.Google Scholar
Drijgers, RL, Dujardin, K, Reijnders, JS, Defebvre, L, Leentjens, AF. Validation of diagnostic criteria for apathy in Parkinson's disease. Parkinson Rel Disord 2010; 16: 656–60.Google Scholar
Leentjens, AF, Dujardin, K, Marsh, L, et al. Anxiety rating scales in Parkinson's disease: critique and recomendations. Mov Disord 2008; 23: 2105–25.Google Scholar
Kirsch-Darrow, L, Fernandez, HF, et al. Dissociating apathy and depression in Parkinson disease. Neurology 2006; 67: 33–8.CrossRefGoogle ScholarPubMed
Starkstein, S, Merello, M, Jorge, R, et al. The syndromal validity and nosological position of apathy in Parkinson's disease. Mov Disord 2009; 15: 1211–16.CrossRefGoogle Scholar
Dujardin, K, Sockeel, P, Devos, D, et al. Characteristics of apathy in Parkinson's disease. Mov Disord 2007; 22: 778–84.CrossRefGoogle ScholarPubMed
Pedersen, KF, Larsen, JP, Alves, G, Aarsland, D. Prevalence and clinical correlates of apathy in Parkinson's disease: a community-based study. Park Rel Disord 2009; 15: 295–9.Google Scholar
Starkstein, S, Leentjens, AF. The nosological position of apathy in clinical practice. J Neurol Neurosurg Psychiatry 2008; 79: 1088–92.CrossRefGoogle ScholarPubMed
Nirenberg, MJ. Dopamine agonist withdrawal syndrome: implications for patient care. Drugs Aging 2013; 30: 587–92.CrossRefGoogle ScholarPubMed
Leentjens, AF, Dujardin, K, Marsh, L, et al. Anxiety rating scales in Parkinson's disease: a validation study of the Hamilton anxiety rating scale, the Beck anxiety inventory and the Hospital anxiety and depression rating scale. Mov Disord 2011; 26: 407–15.CrossRefGoogle Scholar
Dissanayaka, NAD, Selbach, A, Matheson, S, et al. Anxiety disorders in Parkinson's disease: prevalence and risk factors. Mov Disord 2010; 25: 838–45.Google Scholar
Shulman, LM, Taback, RL, Rabinstein, AA, Weiner, WJ. Non-recognition of depression and other non-motor symptoms in Parkinson's disease. Park Rel Disord 2002; 8: 193–7.Google Scholar
Liu, AA, Boxham, CE, Klufas, MA, et al. Clinical predictors of frequent patient telephone calls in Parkinson's disease. Park Rel Disord 2011; 17: 95–9.Google Scholar
American Psychiatric Association. Diagnostic and Statistical Manual V. Washington, DC: American Psychiatric Press, 2013.Google Scholar
Walsh, K, Bennet, G. Parkinson's disease and anxiety. Postgrad Med 2001; 7: 89–93.Google Scholar
Ponton, GM, Williams, JR, Anderson, DE, et al. Prevalence of anxiety disorders and anxiety subtypes in patients with Parkinson's disease. Mov Disord 2009; 24: 1333–8.CrossRefGoogle Scholar
Fleminger, S. Left sided Parkinson's disease is associated with greater anxiety and depression. Psychol Med 1991; 21: 629–38.CrossRefGoogle ScholarPubMed
Leentjens, AF, Dujardin, K, Marsh, L, et al. Anxiety and motor fluctuations in Parkinson's disease: a cross sectional observational study. Park Rel Disord 2012; 18: 1084–8.Google Scholar
Dotchin, CL, Jusabani, A, Walker, RW. Non-motor symptoms in a prevalent population with Parkinson's disease in Tanzania. Park Rel Disord 2009; 15: 457–60.CrossRefGoogle Scholar
Friedman, JH. Parkinson's disease psychosis: Update. Behav Neurol 2013; 27: 469–77.Google Scholar
Zhu, K, van Hilten, JJ, Putter, H, Marinus, J. Risk factors for hallucinations in Parkinson's disease: results from a large prospective cohort study. Mov Disord 2013; 28: 755–62.Google Scholar
Ravina, B, Marder, K, Fernandez, HH, et al. Diagnostic criteria for psychosis in Parkinson's disease: report of an NINDS, NIMH work group. Mov Disord 2007; 22: 1061–8.Google Scholar
Chou, KL, Messing, S, Oakes, D, et al. Drug-induced psychosis in Parkinson's disease: phenomenology and correlations among psychiatric rating scales. Clin Neuropharm 2005; 28: 215–9.Google Scholar
Yoritaka, A, Shimo, Y, Takanashi, M, et al. Motor and non-motor symptoms of 1453 patients with Parkinson's disease: Prevalence and risks. Park Rel Disord 2013; 19: 725–31.CrossRefGoogle ScholarPubMed
Seppi, K, Weintraub, D, Coelho, M, et al. The Movement Disorder Society Evidence-Based Medicine Review Update: treatments for the non-motor symptoms of Parkinson's disease. Mov Disord 2011; (Suppl. 3): S42–80.Google Scholar
Friedman, JH. Pimavanserin in Parkinson's disease psychosis. Expert Opin Pharmacother 2013; 14: 1969–75.CrossRefGoogle ScholarPubMed
Chen, JJ, Marsh, L. Depression in Parkinson's disease: identification and management. Pharmacotherapy 2013; 33: 972–83.Google Scholar
Rocha, FL, Murad, MGR, Stumpf, BP, Hara, C, Fuzikawa, C. Antidepressants for depression in Parkinson's disease: systematic review and meta-analysis. J Psychopharmacol 2013; 27: 417–23.CrossRefGoogle ScholarPubMed
Reijnders, JS, Ehrt, U, Weber, WE, Aarsland, D, Leentjens, AF. A systematic review of prevalence studies of depression in Parkinson's disease. Mov Disord 2008; 23: 183–9.Google Scholar
Hughes, TA, Ross, HF, Mindham, RH, Spokes, EG. Mortality in Parkinson's disease and its association with dementia and depression. Acta Neurol Scand 2004; 110: 118–23.CrossRefGoogle ScholarPubMed
Ravina, B, Camicioli, R, Como, PG, et al. The impact of depressive symptoms in early Parkinson disease. Neurology 2007; 69: 342–7.Google Scholar
Schrag, A, Hovris, A, Morley, D, Quinn, N, Jahanshahi, M. Caregiver burden in Parkinson's disease is closely associated with psychiatric symptoms, falls and disability. Park Rel Dsord 2005; 12: 35–41.CrossRefGoogle ScholarPubMed
Global Parkinson's Disease Survey Steering Committee. Factors impacting on quality of life in Parkinson's disease: results from an international survey. Mov Disord 2002; 17: 60–7.Google Scholar
Ravina, B, Elm, J, Camicioli, R, et al. The course of depressive symptoms in early Parkinson's disease. Mov Disord 2009; 24: 1306–11.Google Scholar
Weintraub, D, Morales, KH, Moberg, PJ, et al. Antidepressant studies in Parkinson's disease: a review and meta-analysis. Mov Disord 2005; 20: 1161–9.Google Scholar
Richard, IH, McDermott, MP, Kurlan, R, et al. A randomized, double-blind, placebo-controlled trial of antidepressants in Parkinson disease. Neurology 2012; 78: 1229–36.Google Scholar
Barone, P, Poewe, W, Albrecht, S, et al. Pramipexole for the treatment of depressive symptoms in patients with Parkinson's disease: a randomized double blind placebo controlled trial. Lancet Neurol 2010; 9: 573–80.CrossRefGoogle Scholar
Moellentine, C, Rummans, T, Ahlskog, JE, et al. Effectiveness of ECT in patients with parkinsonism. J Neuropsychiatr Clin Neurosci 1998; 10: 187–93.CrossRefGoogle ScholarPubMed
Yang, S, Sajatovic, M, Walter, BL. Psychosocial interventions for depression and anxiety in Parkinson's disease. J Geratr Psychiatr Neurol 2012; 25: 113–21.Google Scholar
Friedman, JH, Abrantes, A, Sweet, LH. Fatigue in Parkinson's disease. Exp Opin Pharmacother 2011; 12: 1999–2007.Google Scholar
Lou, JS, Kearns, G, Benice, T, et al. Levodopa improves physical fatigue in Parinson's disease: a double-blind placebo-controlled study. Mov Disord 2003; 18: 1108–14.CrossRefGoogle Scholar
Brown, RG, Dittner, A, Findley, L, Wessely, SC. The Parkinson fatigue scale. Parkinson Rel Disord 2005; 11: 49–55.CrossRefGoogle ScholarPubMed
Krupp, LB, LaRocca, NG, Muir-Nash, J, Steinberg, AD. The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol 1989; 46: 1121–3.CrossRefGoogle ScholarPubMed
Valko, PO, Waldvogel, D, Weller, M, et al. Fatigue and excessive daytime sleepiness in idiopathic Parkinson's disease differently correlate with motor symptoms, depression and dopaminergic treatment. Eur J Neurol 2010; 17: 1428–36.Google Scholar
Alves, G, Wentzel-Larsen, T, Larsen, JP. Is fatigue an independent and persistent symptom in patients with Parkinson's disease? Neurol 2004; 63: 1908–11.Google Scholar
Friedman, JH, Brown, RG, Comella, C, et al. Fatigue in Parkinson's disease: a review. Mov Disord 2007; 22: 297–308.Google Scholar
Friedman, J, Friedman, H. Fatigue in Parkinson's disease. Neurol 1993; 43: 2016–8.Google Scholar
Van Hilten, JJ, Weggeman, M, van der Velde, EA, et al. Sleep, excessive daytime sleepiness and fatigue in Parkinson's disease. J Neural Transm Park Dis Dement Secct 1993; 5: 235–44.CrossRefGoogle ScholarPubMed
Karlsen, K, Larsen, JP, Tandberg, E, Jørgensen, K. Fatigue in patients with Parkinson's disease. Mov Disord 1999; 14: 237–41.Google Scholar
Saez-Francas, N, Hernandez-Vera, J, Corominos Roso, M, Alegre Martín, J, Casas Brugué, M. The association of apathy with central fatigue in patients with Parkinson's disease. Behav Neurosci 2013; 127: 237–44.Google Scholar
Garber, CE, Friedman, JH. Effects of fatigue on physical activity and function in patients with Parkinson's disease. Neurology 2003; 60: 1119–24.Google Scholar
Pavese, N, Metta, V, Bose, SK, Chaudhuri, KR, Brooks, DJ. Fatigue in Parkinson's disease is linked to striatal and limbic serotonergic dysfunction. Brain 2010; 133: 3434–43.Google Scholar
Mendonca, DA, Menezes, K, Jog, MS. Methylphenidate improve fatigue scores in Parkinson's disease: a randomized controlled trial. Mov Disord 2007; 22: 2070–6.CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×